Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 270.00
Bid: 270.00
Ask: 274.00
Change: 0.00 (0.00%)
Spread: 4.00 (1.481%)
Open: 270.00
High: 0.00
Low: 0.00
Prev. Close: 270.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half year post close trading update

7 Jul 2020 07:00

RNS Number : 1830S
Fisher (James) & Sons plc
07 July 2020
 

 

7 July 2020

 

James Fisher and Sons plc (FSJ.L)

 

Half year post close trading update

 

 

James Fisher and Sons plc ("James Fisher" or the "Group"), the leading marine services provider, issues the following post close trading update for the half year to 30 June 2020.

 

Introduction

 

Our priority throughout the Covid-19 pandemic has been to protect our employees and their families and to continue to provide our services and goods to customers, whilst supporting and maintaining our supply chain. The commitment, support and engagement of our employees in stepping up to the challenges of Covid-19 continues to be remarkable and greatly appreciated.

 

Trading update

 

As announced in the Group's AGM statement, the effects of Covid-19 on the Group have been exacerbated by a sharp fall in the price of oil. The imbalance between supply and demand in the oil and gas sector has continued to place downward pressure on oil prices since then and this may persist for some time. Whilst many of the Group's businesses have proven to be resilient through the first half, Group revenue in the second quarter was 18% lower than the comparative period in 2019. For the first half, Group revenue was 10% lower than the comparative period in 2019.

 

In Marine Support, the second quarter saw subsea service projects being deferred, in both renewables and in the oil and gas sector, together with supply chain challenges due to Covid-19 across all businesses. As a result, Marine Support's financial performance will be lower in the first half, year-on-year, despite the ship-to-ship oil transfer business trading strongly during that period. We have taken the decision to restructure the division, reduce the cost base and refresh the management structure which will provide clearer strategic and operational direction going forward.

 

Specialist Technical has performed satisfactorily with both the nuclear and defence segments proving resilient despite some logistical supply chain issues.

 

Offshore Oil, which had good momentum entering 2020, has traded well despite the challenges of Covid-19 and will report improved profitability compared to the first half of 2019. Notably, our artificial oil-well lift business continues to perform well and we have secured a number of marine infrastructure decommissioning projects in Asia during the first half.

 

Tankships traded well through the first four months of 2020, but shipments of clean petroleum products inevitably reduced during May and June as a consequence of the UK and Irish lockdown.

 

Covid-19 mitigating actions and financial position

 

At the start of the Covid-19 pandemic, the Group took immediate actions to protect our people, optimise cash flow and maximise liquidity.

 

This included making use of the Government's furlough scheme, which the Group will shortly stop utilising, coupled with a 20% deferral in salary for around 800 employees for the second quarter. This will be repaid during the second half of the year, except to all Board members and the Executive Committee who have accepted pay cuts of 20% for the second quarter. The Group has returned to full salaries with effect from 1 July.

 

The Group has a strong balance sheet with net debt estimated at approximately £175m at 30 June 2020, compared to £203m at the year end. In the first half of 2020, the Group increased its committed lending facilities by £50m to £300m. Strong cash management and the deferral of payments for dividends, taxes and pensions, together with tight control of costs and capital expenditure, has seen headroom under committed facilities increase from £42m at 31 December 2019 to over £100m at 30 June 2020.

 

Half year results

 

Due to the uncertainties surrounding our markets at the time of our AGM on 30 April 2020, the Group withdrew financial guidance for the year. While the intervening months have continued to present challenges, the Group has proven resilient and performed well in the circumstances.

 

James Fisher is well diversified by geographical sector and by end markets which provides resilience to profitability and cash flow, most notably in the current environment. The Group's half year results are scheduled to be announced on 25 August 2020.

 

 

 

 

For further information:

James Fisher and Sons plc

Eoghan O'Lionaird

Stuart Kilpatrick

Chief Executive Officer

Group Finance Director

020 7614 9508

FTI Consulting

Richard Mountain

Susanne Yule

 

0203 727 1340

 

Forward-looking statements

This announcement contains statements which are, or may be deemed to be, "forward-looking statements" which are prospective in nature. All statements other than statements of historical fact are forward-looking statements. By their nature, forward-looking statements are subject to a number of known and unknown risks, uncertainties and contingencies, and actual results and events could differ materially from those currently being anticipated as reflected in such statements. Factors may cause future outcomes to differ from those foreseen or implied, many of which are beyond James Fisher's control or influence. Any forward-looking statements speak only as of the date of this announcement and have not been audited or otherwise independently verified. Past performance should not be taken as an indication or guarantee of future results and no representation or warranty, express or implied, is made regarding future performance. Except as required by any applicable law or regulation, James Fisher expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statements contained in this announcement to reflect any change in the Group's expectations or any change in events, conditions or circumstances on which any such statement is based after the date of this announcement, or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on any forward-looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTRFMPTMTBMBJM
Date   Source Headline
22nd Mar 20224:35 pmRNSHolding(s) in Company
10th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
24th Jan 202210:54 amRNSDirector Declaration
29th Dec 20219:55 amRNSMozambique update
17th Dec 20217:00 amRNSAppointment of non-executive director
15th Dec 20215:36 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:22 pmRNSHolding(s) in Company
18th Nov 202110:25 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSale of James Fisher Testing Services for £5.7m
1st Nov 20215:23 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSTrading update
22nd Oct 20218:00 amRNSAppointment of non-executive director
15th Sep 20211:26 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf year results for the 6 months ended 30 Jun 21
1st Jul 20217:00 amRNSSale of Paladin for US$17.3m
29th Jun 20217:00 amRNSCapital Markets Event & Pre Close Trading Update
15th Jun 20213:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jun 20214:16 pmRNSDirector/PDMR Shareholding
30th Apr 202111:59 amRNSDirector Declaration
29th Apr 20212:01 pmRNSResult of Annual General Meeting
29th Apr 20217:00 amRNSAGM Trading Statement
20th Apr 20217:00 amRNSAppointment of Chief Financial Officer
13th Apr 202111:32 amRNSWithdrawal of Annual General Meeting Resolution
9th Apr 202110:18 amRNSDirector/PDMR Shareholding
8th Apr 20213:58 pmRNSDirector/PDMR Shareholding
6th Apr 20213:48 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights and Share Capital
29th Mar 20217:00 amRNSDirectorate Change
23rd Mar 202112:58 pmRNSAnnual Report and Notice of AGM posted
19th Mar 20211:17 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSResults for the year ended 31 December 2020
25th Feb 202110:42 amRNSNotification of FY Results Date
25th Jan 20217:00 amRNSAngus Cockburn appointed as Chairman
7th Jan 20217:00 amRNSPost close trading update
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 202011:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:25 pmRNSTotal Voting Rights
6th Nov 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSTotal Voting Rights
23rd Oct 20209:48 amRNSDirector/PDMR Shareholding
6th Oct 20203:58 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSRoyal Navy contract award
21st Sep 20204:00 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSHalf-year results
24th Jul 202012:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.